amifostine anhydrous has been researched along with Carcinoma, Adenosquamous in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Carcinoma, Adenosquamous: A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blohmer, JU | 1 |
| Paepke, S | 1 |
| Böhmer, D | 1 |
| Ernhardt, B | 1 |
| Sehouli, J | 1 |
| Elling, D | 1 |
| Lichtenegger, W | 1 |
1 trial available for amifostine anhydrous and Carcinoma, Adenosquamous
| Article | Year |
|---|---|
[Adjuvant chemotherapy of cervix carcinoma--results of a phase II study].
Topics: Adenocarcinoma; Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin | 2001 |